Phase III clinical trials represent the final phase of clinical testing for a new drug or treatment. These large-scale trials involve hundreds or thousands of human subjects to confirm the drug's effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug to be used safely. After Phase III trials are completed, the results are compiled and submitted to the FDA in a New Drug Application for review and potential approval.